Analysis of perfluorochemical elimination from the respiratory system. J. Appl. Physiol. 83(3): 1033-1040, 1997.-We describe a simple apparatus for analysis of perfluorochemicals (PFC) in expired gas and thus a means for determining PFC vapor and liquid elimination from the respiratory system. The apparatus and data analysis are based on thermal conduction and mass transfer principles of gases. In vitro studies were conducted with the PFC vapor analyzer to determine calibration curves for output voltage as a function of individual respiratory gases, respiratory gases saturated with PFC vapor, and volume percent standards for percent PFC saturation (%PFC-Sat) in air. Voltage-concentration data for %PFC-Sat of the vapor from the in vitro tests were accurate to within 2.0% from 0 to 100% PFC-Sat, linear (r ϭ 0.99, P Ͻ 0.001), and highly reproducible. Calculated volume loss of PFC liquid over time correlated well with actual loss by weight (r ϭ 0.99, P Ͻ 0.001). In vivo studies with neonatal lambs demonstrated that PFC volume loss and evaporation rates decreased nonlinearly as a function of time. These relationships were modulated by changes in PFC physical properties, minute ventilation, and postural repositioning. The results of this study demonstrate the sensitivity and accuracy of an on-line method for PFC analysis of expired gas and describe how it may be useful in liquid-assisted ventilation procedures for determining PFC volume loss, evaporation rate, and optimum dosing and ventilation strategy. thermal detectors; premature lambs; liquid ventilation; evaporation rate of perfluorochemicals IT HAS BEEN EXTENSIVELY reported that liquid-assisted ventilation, tidal and partial liquid ventilation utilizing perfluorochemical (PFC) liquids, can reduce interfacial surface tension and provide improved ventilation at low insufflation and alveolar pressures in cases of restrictive lung disease (20, 22) . Liquid ventilation supports effective arterial oxygenation, CO 2 elimination, homogeneous distribution of ventilation, and pulmonary perfusion (15, 17) . In addition to the fact that PFC liquids are bioinert, it has been shown that they are minimally absorbed, eliminated from the lungs primarily by evaporation, and have no deleterious histological, cellular, or biochemical effects (10, 13, 17, 24) . The potential usefulness of PFC liquid has been investigated in animal models and in humans with respiratory distress syndrome (2, 4, 6, 8, 9, 11, 21, 22), pulmonary administration of drugs (14, 23), radiologic imaging and diagnosis (5, 19, 25) , and artificial red blood cell substitution (1, 12) . In all these modalities, it is important to evaluate PFC vapor elimination via respiration to monitor PFC distribution and supplemental dosing with respect to ventilatory management. In this study we characterize PFC elimination from the respiratory system utilizing a simple, on-line thermal detector analyzer. The conceptual design and basic operative considerations of the detector and representative in vitro and in vivo data acquired by use of this technique are also presented.
IT HAS BEEN EXTENSIVELY reported that liquid-assisted ventilation, tidal and partial liquid ventilation utilizing perfluorochemical (PFC) liquids, can reduce interfacial surface tension and provide improved ventilation at low insufflation and alveolar pressures in cases of restrictive lung disease (20, 22) . Liquid ventilation supports effective arterial oxygenation, CO 2 elimination, homogeneous distribution of ventilation, and pulmonary perfusion (15, 17) . In addition to the fact that PFC liquids are bioinert, it has been shown that they are minimally absorbed, eliminated from the lungs primarily by evaporation, and have no deleterious histological, cellular, or biochemical effects (10, 13, 17, 24) . The potential usefulness of PFC liquid has been investigated in animal models and in humans with respiratory distress syndrome (2, 4, 6, 8, 9, 11, 21, 22), pulmonary administration of drugs (14, 23) , radiologic imaging and diagnosis (5, 19, 25) , and artificial red blood cell substitution (1, 12) . In all these modalities, it is important to evaluate PFC vapor elimination via respiration to monitor PFC distribution and supplemental dosing with respect to ventilatory management. In this study we characterize PFC elimination from the respiratory system utilizing a simple, on-line thermal detector analyzer. The conceptual design and basic operative considerations of the detector and representative in vitro and in vivo data acquired by use of this technique are also presented.
MATERIALS AND METHODS
Detector and analyzer operation. The PFC thermal detector is a modification of a commercial thermal cell (Warren Collins, Braintree, MA) composed of a dual-chambered, brass heat block that has one thermistor in each chamber (Fig. 1A) . Sample gas flow results in a change in temperature in one chamber (sample cell) compared with the other chamber (reference cell). The reference cell is sealed with dry tank air. These thermistors are connected in a balanced bridge circuit, such that an unbalanced bridge (temperature difference between chambers) will result in a linear voltage output that is proportional to chamber temperature difference [linearity: 0.2%; accuracy: 0.1% of full scale (analog) and 0.02% of full scale (digital)]. This voltage output was amplified with a high-gain linear amplifier (analog output 0-15 V) and compensated for variations in room and sample gas temperatures. The amplified voltage output () represents the thermal detector output with thermal compensation. By maintaining the sample gas flow constant (500 ml/min), the reference gas flow equal to zero (sealed chamber), and the reference gas composition constant during normal operation, the voltage output of the detector will change as a function of the composition and physical thermal properties of the sample gas. Therefore, the detector can be calibrated for respiratory gases saturated or partially saturated with PFC vapor.
As shown in Fig. 1B , the analyzer was used in three modes of operation: 1) standby, 2) calibration or continuous flow, and 3) discrete expiratory gas sampling mode. The electronic and pneumatic circuit operation for all these modes is illustrated and described in detail in the legend of Fig. 1B . For the standby mode, gas is continuously circulated within the analyzer circuit during a 15-min warm-up period or between experimental data collections. In the continuous modes of operation, the PFC detector was used to continuously sample gas flow from PFC calibration sources, an in vitro test apparatus, and in vivo tracheal gas samples. Finally, in the discrete expiratory gas sampling mode, the PFC detector was integrated into an on-line gas sampling circuit, such that gas sampling was facilitated by means of external electronically triggered solenoid valves (Fluorocarbon, Anaheim, CA). By use of this system, it was possible for an operator to synchronize the open/closed position of the valves, such that gas samples were collected only during the expiratory phase of ventilation. This procedure was facilitated by observing the phase of the ventilator and chest wall motion. In this discrete expiratory sampling mode, the digital output voltage reflected an average of percent PFC saturation in expired gas.
In vitro calibration and testing. Calibrated, medical-grade test gases (100% O 2 ; 100% N 2 ; 5% He-95% air; 3% He-97% air; 1% He-99% air; 3.5% CO 2 -96.5% air; and air; AIRCO) were passed through the thermal detector (500 ml/min) and analyzer circuit (4,500 ml/min) at a constant flow and temperature (25°C). In addition, several gases were studied dry and with 100% saturated water vapor to determine the effect of water vapor on the thermal detector. Resultant temperature differences between the two thermistors were assessed as differences in voltage signal, designated as . In addition, respiratory gases saturated with the vapor from several PFC liquids were sampled (see Table 1 for PFC specifications: vapor pressures were calculated on the basis of software provided by the National Institute of Standards and Technology, ''Structures and Properties,'' version 2.0). PFC liquids studied in this investigation included perflubron (LiquiVent, Alliance Pharmaceutical), perfluoroalkylfuran (Rimar 101, Miteni, represented in the US by Mercantile Development), perfluorodecalin (APF-140, Air Products and Chemicals), and perfluorodimethyl-cyclohexane (APF-125, Air Products and Chemicals).
To further characterize the heat transfer properties of the thermal detector, the Nusselt number (Nu), an index of heat transfer, was calculated for sampled respiratory gases (7). Nu was calculated using the following equation
where is density, C p is specific heat, and k is thermal conductivity of the medium. For mixtures of gases (i.e., He-air), the calculated value of each physical property (, C p , k) is based on its volumetric proportion of the mixture. The voltage output of the detector () was then assessed for linearity and sensitivity as a nondimensional function of Nu for various respiratory gases combined with various saturations of PFC vapors (0-100%). The volume percentage of PFC vapor saturated in test gas (%PFC-Sat) was determined as follows %PFC-Sat ϭ (Vol PFC vapor/Sat Vol PFC vapor) ϫ 100 (2) where, for a given PFC liquid, the saturated volume of PFC vapor (Sat Vol PFC vapor) was determined as Sat Vol PFC vapor ϭ P v /P b ϫ 100
where P b is the barometric pressure of dry test gas, and P v is the vapor pressure of PFC at a specific temperature. As shown in Table 2 , content (ml or g of PFC per ml of atmospheric gas) at 100% PFC-Sat varies as a function of PFC liquid and temperature, since vapor pressure is a function of temperature (Table 1) . PFC liquid volume loss due to volatilization was calculated using the following mathematical relationship PFC liquid loss
where V is the gas flow or minute ventilation (ml/min), %PFC-Sat is the measured volumetric percentage of PFC vapor in the sample gas, (ml PFC fluid/ml vapor) is based on molecular weight and density of the PFC liquid and temperature, and t is time (min). Calculated volume loss at room temperature conditions (25-26.5°C) was then compared with actual PFC fluid loss from a 200-ml glass flask for a calibrated, constant gas flow (medical-grade air, 500 ml/min; Cole-Palmer rotameter, 150-mm variable-area flowmeter, Niles, IL) that was bubbled under the surface of the liquid PFC. Flasks were initially filled with 100 ml (high-volume condition) or 50 ml (low-volume condition) of PFC liquid (LiquiVent or Rimar 101) and allowed to evaporate over time while volume loss was determined gravimetrically using a digital scale (model SL 5000, Scientech) and the appropriate PFC specific gravities. The high initial volume condition maintained 100% saturation, while the low initial volume condition allowed a change in gas/PFC surface area as PFC fluid evaporated from the flask.
In vivo studies. Assessment of expired %PFC-Sat, PFC volume loss, and rate of volume loss was conducted in five preterm lambs (125 days gestation). The animals were managed according to National Institutes of Health regulations and the ''Guiding Principles in the Care and Use of Animals'' of the American Physiological Society. In addition, the study was performed with the approval of the Temple University Medical School Animal Care Committee.
The pregnant ewe was sedated with ketamine (5.0 ml/kg im) followed by epidural administration of 1.0 mg/kg of 0.75% bupivacaine HCl. Cesarean section was performed while the ewe was restrained in the prone position, as previously described (16, 22) .
The uterus was exposed and opened sufficiently for the head of the fetal lamb to emerge, and a rubber glove containing warmed saline solution was placed over its snout to prevent inspiration. Skin and superficial tissues were anesthetized (4.0 mg/kg of 5% lidocaine). Ketamine (1 mg/kg im) was given, and catheters were placed in a jugular vein and carotid artery. A tracheotomy was performed, and a Hi-Lo jet endotracheal tube (Mallinckrodt) was introduced, with the tip inserted proximal to the carina. Pancuronium bromide (0.10 mg/kg) and sodium bicarbonate (2.50 meq/kg) were administered intravenously before the rubber glove was removed, and the lamb was then delivered. Animals were ventilated using an InfantStar (Infrasonics) pressure ventilator, using conventional management [tidal volume (VT) ϭ 6-10 ml/kg, respiratory rate ϭ 30 breaths/min, inspiratory O 2 fraction ϭ 1 saturated with water at 37°C]. Respiratory parameters of VT, breathing frequency, and minute ventilation were determined by computed pneumotachography (PEDS, MAS).
After tracheal administration of PFC liquid (10 ml/kg, LiquiVent) over 5 min, the PFC analyzer circuit was placed in-line. Mixed expired gas was collected by means of a low dead space (VD) sample chamber (1.5 ml) placed in series with the ventilator (Fig. 1B) . A circulating pump (model KNF, Neuberger, Trenton, NJ), calibrated to a known flow rate, was synchronized with the ventilator by means of an electronic trigger and solenoid valves that allowed sampling of expired gas and assessment of %PFC-Sat. Thus a synchronized sampling system was created, such that respiratory gas samples were removed from the airways, analyzed, and reintroduced into the breathing circuit. Hence, no net gas was added or removed from the system.
In preliminary studies with partial liquid ventilation (PLV), simultaneous mixed expired gas and arterial blood-gas samples were collected after the intratracheal instillation of PFC and analyzed (Stat Profile 3, NOVA Biomedical) for CO 2 . These studies were conducted to test a simple algorithm utilizing arterial PCO 2 (Pa CO 2 ) as an indirect means for in vivo correction of %PFC due to small alterations in expiratory CO 2 fraction (FE CO 2 ) of carrier gas, since the thermal detector is not specific to PFC vapor. As previously reported by Tutuncu et al. (21) 
However, the indirect approximation of FE CO 2 based on measured Pa CO 2 determinations was comparable to simultaneously measured FE CO 2 samples evaluated on the NOVA blood-gas analyzer. These relationships are dependent on a number of physiological and pathological factors that may vary between animal models and/or clinical pulmonary diseases. Thus we recommend that, for general use, %PFC-Sat carrier gas corrections be based on actual expired gas concentrations of CO 2 (and where necessary O 2 and water vapor); however, when direct samples of FE CO 2 are not available, the above algorithm may provide an indirect method for in vivo correction of %PFC-Sat due to alterations in FE CO 2 . %PFC-Sat of expired gases was monitored over time and provided continuous evaluation of PFC vapor concentration, liquid volume loss, and rate of liquid volume loss. The effects of ventilation duration, minute ventilation, and repositioning of animals were examined. In addition, arterial blood gases, chemistries, and expired gas concentrations were sequentially monitored (Stat Profile 3, NOVA Biomedical).
RESULTS

In vitro data.
Calculated Nu values for respiratory gases were plotted vs. measured values to establish a standard curve for the given range of the thermal detector. As shown in Fig. 2A , a linear correlation (r ϭ 0.92, P Ͻ 0.001) was established between Nu for respiratory gases and measured . Additionally, three PFC vapors combined with respiratory gases were sampled in the in vitro circuit, and as noted in Fig. 2B , there was a linear correlation (r ϭ 0.97, P Ͻ 0.001) between and %PFC-Sat ϫ Nu for each carrier gas (O 2 , air, N 2 ) in combination with PFC vapor. Each data point represents the mean of five repeated measurements for each carrier gas/PFC concentration. These experiments were repeated extensively and found to be reproducible within 2% variation. It is also noteworthy that the slopes (⌬/⌬%PFC-Sat ϫ Nu) of carrier gases saturated with PFC vapor were similar; however, their intercepts were shifted as a function of carrier gas baseline (no PFC), as noted in Fig. 2B .
plotted as a function of PFC vapor concentration was linear for each PFC studied (Fig. 2C) . As summarized in Table 3 , all -concentration curves were linear over the concentration range 0-100% PFC-Sat, and the slope of each line was PFC dependent. When the physical properties of the various PFC liquids were considered (Table 1) , it was noted that the slope [thermal detector sensitivity (TDS)] of the -%PFC-Sat curves increased as a function of PFC liquid vapor pressure. Regression analysis of these data (Table 3) showed that TDS ϭ Ϫ0.097P v ϩ 8.43 (r ϭ 0.99, P Ͻ 0.01), thus demonstrating that the sensitivity of the PFC analyzer increased in proportion to PFC vapor pressure. Although not shown in Fig. 2 , the presence of O 2 , CO 2 , and 100% saturated water vapor shifted each curve (-%PFC-Sat) upward 0.02 V/1% increase in O 2 concentration, 0.146 V/1% decrease in CO 2 concentration, and 0.039 V/10% increase in water vapor concentration. Therefore, the intercept of the -%PFC-Sat curve was shifted as noted above; however, the TDS (slope) for each PFC was independent of carrier gas concentration. On the basis of these experimental data, we calculated that the combined effect of 2.79% CO 2 and 100% saturated water vapor in mixed expired gas would essentially nullify any individual offsets in thermal detector signal. However, when mixed expired CO 2 exceeds the normal range of 2.5% Ͻ CO 2 Ͻ 4%, must be appropriately corrected for CO 2 . Moreover, as shown in Fig. 2C , the significance of water vapor, CO 2 , and O 2 compensation is less critical for higher vapor pressure liquids (APF-125 and Rimar 101) than for low vapor pressure liquids (APF-140 and LiquiVent). (Fig. 3C) and low (Fig. 3D) vapor pressure fluids was identical.
In vivo data. All preterm lambs were ventilated with conventional mechanical gas ventilation while PFC (LiquiVent) was slowly infused. After a functional residual capacity (10 ml/kg) volume was introduced, the initial PFC liquid lung volume and rate of PFC volume loss were 10 ml/kg and 0.055 Ϯ 0.009 (SE) ml·kg Ϫ1 · min Ϫ1 , respectively (Fig. 4) . There was a nonlinear decrement in these parameters over 2 h of gas ventilation, which was experimentally derived by direct %PFC-Sat determinations and calculations utiliz- ing Eq. 4. As noted above, changes in %PFC-Sat for water vapor and CO 2 were taken into consideration. During this 2-h study, arterial oxygenation, PCO 2 , and pH were effectively maintained [arterial PO 2 ϭ 136 Ϯ 53 (SE) Torr, Pa CO 2 ϭ 48 Ϯ 5 Torr, pH ϭ 7.31 Ϯ 0.03]. As expected from Eq. 4, it was experimentally determined that the PFC lung volume and PFC rate of loss were related to time (Fig. 4) , such that both decreased over the 2 h of ventilation. In addition, as shown in Fig. 5A , in two lambs that required very different minute ventilation to maintain normocapnia, volume loss (3.8 vs. 7.5 ml/kg) increased in approximate proportion to minute ventilation (209.9 vs. 409.3 ml/ min); other respiratory gas conditions (saturated water vapor and inspiratory O 2 fraction ϭ 1.0) were maintained. Finally, as shown in Fig. 5B , %PFC-Sat decreased over the 2 h of ventilation, and a change in animal posture at 140 min with no instillation of PFC fluid resulted in a transient increase of ϳ20% in %PFC-Sat (supine to prone). Also, a later position change (prone to supine) at 200 min resulted in a smaller increase of 5% in %PFC-Sat (prone to supine).
DISCUSSION
The process reported here relates to a method of evaluating liquid PFC vapor elimination via the respiratory system. PFC elimination analysis utilizing an on-line thermal detector provides a useful and convenient method for continuous determination of %PFC-Sat in expired gas and a means of accurately determining PFC volume loss and rate of volume loss from the lungs.
As previously discussed, to maintain effective ventilation during liquid-assisted ventilation, it is of value to have a continuous assessment of the amount of PFC in the lung as well as the relative distribution of PFC throughout the lung. However, because of the inevitable evaporation of PFC from the respiratory system, liquid volume and distribution of PFC throughout the lungs vary over the duration of gas ventilation. This evaporative process and redistribution have been documented in short-and long-term radiographic studies in experimental animals and humans after administration of various amounts of PFC to the lungs (4-6, 8, 19, 25) .
Previous methods for assessment of expired PFC vapor and liquid volume loss during liquid-assisted ventilation have been problematic. The approaches have been encumbered by inconvenient sampling techniques as well as the expense of gas chromatography or mass spectroscopy technology required to obtain quantitative gas values (10, 14, 16) . Furthermore, radiographic evaluation or visual observation of a ''meniscus'' of PFC liquid in the endotracheal tube is qualitative at best (3, 5, 6, 8) . None of these methods has provided a convenient and effective means for continuously and accurately assessing the amount PFC vapor in expired gas, PFC liquid in the lungs, or the volume of PFC loss over time. In addition, over the course of treatment, inaccurate evaluation of PFC lung volume could result in over-or underexpansion of the lung, thus resulting in suboptimal ventilation strategy.
As shown in the present study, %PFC-Sat, PFC lung volume, and PFC loss rate from the lungs of premature lambs decrease as a function of time during conventional gas ventilation. These parameters can be modulated by changes in minute ventilation and repositioning (Fig. 5) . Therefore, %PFC-Sat is associated with the amount as well as the distribution of PFC liquid in the lung. It is also noteworthy that additional dosing coupled with postural repositioning and redistribution of PFC liquid in the lung, while providing improved PFC protection of the lung surface from barotrauma, may also promote increased respiratory PFC fluid loss due to an increase in %PFC-Sat. Thus maintenance of a high %PFC-Sat in the lungs might suggest better protection of the respiratory system during mechanical ventilation. As indicated here, high %PFC-Sat in expired respiratory gas immediately after filling may be associated with an adequate volume and uniform distribution of PFC liquid in the lungs, both of which appear to correlate with good physiological function. The maintenance of a stable volume (Ͼ10 ml/kg) and uniform distribution of PFC in the lungs could perhaps be best facilitated by frequent or continuous dosing and/or postural repositioning.
The thermal detector utilized for PFC vapor analysis in this study would be best categorized as a universal (nonspecific) detector, in that it is sensitive in various degrees to respiratory gases and water vapor as well as to PFC vapors. Thermal detector technology has been used extensively in gas chromatography because of its simplicity, low cost, and universality. However, the nonspecific nature of thermal detectors, while beneficial at times, requires additional consideration for the possible presence of other gases. All in vitro studies described here were conducted under controlled conditions where only one PFC was under analysis at any one time and calibrations were determined for specific carrier gas concentrations. Under similar conditions, in all in vivo studies only one PFC (LiquiVent) was tested; calibrations were determined for constant temperature, O 2 , and saturated water vapor conditions, and small variations in expired CO 2 were corrected as described in RESULTS (In vitro data) . For future applications, thermal detector compensation and improved gas specificity are being explored with the addition of miniature in-line O 2 , CO 2 , and water vapor sensors to electronically correct for background carrier gas concentrations. In addition, a triggering system has been designed, such that a pressure threshold (e.g., 3 cmH 2 O) can be electronically set so that the solenoids are activated when ventilator pressure is less than threshold pressure. This signal indicates the start of expiration. The expiratory time (TE) is set on the analyzer to match that of the ventilator (e.g., 2.0 s), and sampling time can be adjusted between 20 and 80% of TE, such that gas sampling can be varied during expiration. This new system configuration is more user friendly and reduces operator error in valve triggering; however, on the basis of pilot study results of various expiratory sampling times between 20 and 80% of TE, this feature does not appear to significantly vary our calculation of %PFC compared with the results reported here.
In conclusion, this investigation has described a convenient and inexpensive means for continuous evaluation of PFC vapor in expired gas samples. The results of this study 1) demonstrate the sensitivity, specificity, range, and accuracy of an on-line method for in vitro analysis of several PFC vapors, 2) characterize the changes in %PFC-Sat in expired gas, PFC volume loss, and rate of volume loss from the lungs of preterm lambs during gas ventilation, and 3) describe the implications of this technique in liquid-assisted ventilation applications. The analyzer described in this report may also be useful for several other PFC biomedical applications, such as in liquid ventilation, drug delivery, radiologic imaging, and blood substitution.
